Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Cancers|October 20, 2020
LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric AdenocarcinomaYuan Li, Shumei Song, Melissa Pool Pizzi, et al.Cancer Research|August 3, 2002
Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumorsMarielle Fournel, Marie-Claude Trachy-Bourget, P Theresa Yan, et al.The Journal of Pharmacology and Experimental Therapeutics|September 3, 2015
Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1Sanjay K Pandey, Thurman M Wheeler, Samantha L Justice, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.Communications Biology|November 2, 2021
Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recyclingAlexander N Kapustin, Paul Davey, David Longmire, et al.Bioorganic & Medicinal Chemistry Letters|April 14, 2009
SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymesOscar M Saavedra, Ljubomir Isakovic, David B Llewellyn, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitorsLjubomir Isakovic, Oscar M Saavedra, David B Llewellyn, et al.Nucleic Acid Therapeutics|March 1, 2019
IONIS-PKKRx a Novel Antisense Inhibitor of Prekallikrein and Bradykinin ProductionJason D Ferrone, Gourab Bhattacharjee, Alexey S Revenko, et al.Nucleic Acid Therapeutics|May 23, 2013
Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeysSebastien A Burel, So-Ri Han, Hong-Soo Lee, et al.Journal of Medicinal Chemistry|February 21, 2003
Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitorsGiliane Bouchain, Silvana Leit, Sylvie Frechette, et al.Pageof 9